Publication | Closed Access

Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells

InflammationVascular DiseaseTissue Factor ExpressionVasculitisSystemic Lupus ErythematosusAutoimmune DiseaseLupusSystemic Lupus Erythematosus TreatmentImmunologyPathologyAutoimmunityAutoantibodiesVascular BiologyAnti-phospholipid AntibodiesMedicineAtherosclerosis